α2-Macroglobulin, lipoprotein receptor-related protein and lipoprotein receptor-associated protein and the genetic risk for developing Alzheimer's disease

Neuroscience Letters

Volumn 400, Issue 3, 2006, Pages 187-190

  Depboylu, Candan ^a   Lohmüller, Frank ^a   Du, Yansheng ^b   Riemenschneider, Matthias ^c   Kurz, Alexander ^c   Gasser, Thomas ^d   Müller, Ulrich ^e   Dodel, Richard C ^f  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF TÜBINGEN   (Germany)

^e JUSTUS LIEBIG UNIVERSITY   (Germany)

^f UNIVERSITY OF BONN   (Germany)

Author keywords

Amyloid; Dementia; Inflammation; Lipoprotein; Polymorphism

Indexed keywords

ALPHA 2 MACROGLOBULIN; APOLIPOPROTEIN E4; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; RECEPTOR PROTEIN;

ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENDER; GENETIC RISK; GENOTYPE; HUMAN; INHERITANCE; MAJOR CLINICAL STUDY; MALE; METABOLISM; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; AGED; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GERMANY; INCIDENCE; METHODOLOGY; MIDDLE AGED; RISK FACTOR; SEX RATIO;

AGED; AGED, 80 AND OVER; ALPHA-MACROGLOBULINS; ALZHEIMER DISEASE; COHORT STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GERMANY; HUMANS; INCIDENCE; LDL-RECEPTOR RELATED PROTEIN 1; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION;

EID: 33646265052     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.01.040     Document Type: Article

References (24)

1. Back S.A., and Alhadeff J.A. Differential isoform profiles of alpha 2-macroglobulin from plasma of patients with chronic-progressive or relapsing-remitting multiple sclerosis. Clin. Chim. Acta 211 (1992) 27-36
2. Blacker D., Wilcox M.A., Laird N.M., Rodes L., Horvath S.M., Go R.C., Perry R., Watson Jr. B., Bassett S.S., McInnis M.G., Albert M.S., Hyman B.T., and Tanzi R.E. Alpha-2 macroglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19 (1998) 357-360
3. Borth W., and Luger T.A. Identification of alpha 2-macroglobulin as a cytokine binding plasma protein. Binding of interleukin-1 beta to "F" alpha 2-macroglobulin. Biol. Chem. 264 (1989) 5818-5825
4. Crawford F., Town T., Freeman M., Schinka J., Gold M., Duara R., and Mullan M. The alpha-2 macroglobulin gene is not associated with Alzheimer's disease in a case-control sample. Neurosci. Lett. 270 (1999) 133-136
5. Dodel R.C., Du Y., Bales K.R., Gao F., Eastwood B., Glazier B., Zimmer R., Cordell B., Hake A., Evans R., Gallagher-Thompson D., Thompson L.W., Tinklenberg J.R., Pfefferbaum A., Sullivan E.V., Yesavage J., Alstiel L., Gasser T., Farlow M.R., Murphy Jr. G.M., and Paul S.M. Alpha2 macroglobulin and the risk of Alzheimer's disease. Neurology 54 (2000) 438-442
6. Du Y., Bales K.R., Dodel R.C., Liu X., Glinn M.A., Horn J.W., Little S.P., and Paul S.M. Alpha2-macroglobulin attenuates beta-amyloid peptide 1-40 fibril formation and associated neurotoxicity of cultured fetal rat cortical neurons. J. Neurochem. 70 (1998) 1182-1188
7. Hollenbach E., Ackermann S., Hyman B.T., and Rebeck G.W. Confirmation of an association between a polymorphism in exon 3 of the low-density lipoprotein receptor-related protein gene and Alzheimer's disease. Neurology 50 (1998) 1905-1907
8. Hyman B.T., Strickland D., and Rebeck G.W. Role of the low-density lipoprotein receptor-related protein in beta-amyloid metabolism and Alzheimer disease. Arch. Neurol. 57 (2000) 646-650
9. Kamboh M.I., Ferrell R.E., and DeKosky S.T. Genetic association studies between Alzheimer's disease and two polymorphisms in the low density lipoprotein receptor-related protein gene. Neurosci. Lett. 244 (1998) 65-68
10. Kang D.E., Saitoh T., Chen X., Xia Y., Masliah E., Hansen L.A., Thomas R.G., Thal L.J., and Katzman R. Genetic association of the low-density lipoprotein receptor-related protein gene (LRP), an apolipoprotein E receptor, with late-onset Alzheimer's disease. Neurology 49 (1997) 56-61
11. Kounnas M.Z., Moir R.D., Rebeck G.W., Bush A.I., Argraves W.S., Tanzi R.E., Hyman B.T., and Strickland D.K. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation. Cell 82 (1995) 331-340
12. Liao A., Nitsch R.M., Greenberg S.M., Finckh U., Blacker D., Albert M., Rebeck G.W., Gomez-Isla T., Clatworthy A., Binetti G., Hock C., Mueller-Thomsen T., Mann U., Zuchowski K., Beisiegel U., Staehelin H., Growdon J.H., Tanzi R.E., and Hyman B.T. Genetic association of an alpha2-macroglobulin (Val1000lle) polymorphism and Alzheimer's disease. Hum. Mol. Genet. 7 (1998) 1953-1956
13. Leuven F.V., Thiry E., Stas L., and Nelissen B. Analysis of the human LRPAP1 gene coding for the lipoprotein receptor-associated protein: identification of 22 polymorphisms and one mutation. Genomics 52 (1998) 145-151
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., and Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34 (1984) 939-944
15. Meyer M.R., Tschanz J.T., Norton M.C., Welsh-Bohmer K.A., Steffens D.C., Wyse B.W., and Breitner J.C. APOE genotype predicts when-not whether-one is predisposed to develop Alzheimer disease. Nat. Genet. 19 (1998) 321-322
16. Narita M., Holtzman D.M., Schwartz A.L., and Bu G. Alpha2-macroglobulin complexes with and mediates the endocytosis of beta-amyloid peptide via cell surface low-density lipoprotein receptor-related protein. J. Neurochem. 69 (1997) 1904-1911
17. Nathan B.P., Bellosta S., Sanan D.A., Weisgraber K.H., Mahley R.W., and Pitas R.E. Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264 (1994) 850-852
18. Rebeck G.W., Harr S.D., Strickland D.K., and Hyman B.T. Multiple, diverse senile plaque-associated proteins are ligands of an apolipoprotein E receptor, the alpha 2-macroglobulin receptor/low-density-lipoprotein receptor-related protein. Ann. Neurol. 37 (1995) 211-217
19. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J., Hulette C., Crain B., Goldgaber D., and Roses A.D. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43 (1993) 1467-1472
20. Strauss S., Bauer J., Ganter U., Jonas U., Berger M., and Volk B. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab. Invest. 66 (1992) 223-230
21. Wang X., Luedecking E.K., Minster R.L., Ganguli M., DeKosky S.T., and Kamboh M.I. Lack of association between alpha2-macroglobulin polymorphisms and Alzheimer's disease. Hum. Genet. 108 (2001) 105-108
22. Wavrant-DeVrieze F., Rudrasingham V., Lambert J.C., Chakraverty S., Kehoe P., Crook R., Amouyel P., Wu W., Holmans P., Rice F., Perez-Tur J., Frigard B., Morris J.C., Carty S., Cottel D., Tunstall N., Lovestone S., Petersen R.C., Chartier-Harlin M.C., Goate A., Owen M.J., Williams J., and Hardy J. No association between the alpha-2 macroglobulin I1000V polymorphism and Alzheimer's disease. Neurosci. Lett. 262 (1999) 137-139
23. Willnow T.E., Armstrong S.A., Hammer R.E., and Herz J. Functional expression of low-density lipoprotein receptor-related protein is controlled by receptor-associated protein in vivo. Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 4537-4541
24. World Health Organization, The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines, Geneva, Switzerland, World Health Organization, 1992, pp. 50-51.